Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
  • 12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research
  • 12/25/2024Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations
  • 12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
  • 12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
  • 12/25/2024NMPA Announces Package Insert Revision of Human Tetanus Immunoglobulin...
  • 12/24/2024Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...
  • 12/24/2024Fosun Pharma's Parent Company Pledges 27% of Its A-shares
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024 Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
  • 12/24/2024CDE Seeks Comments on the Supplementary List of External Experts for t...
  • 12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
  • 12/23/2024RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
  • 12/23/2024CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
  • 12/23/2024Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
  • 12/23/2024MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
  • 12/23/2024Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
  • 12/23/2024Shionogi Acquires Pingan's Stake in AI-Focused JVs
  • 12/22/2024Deputy NMPA Commissioner Attends GHWP Annual Meeting
  • 12/20/2024Recent Executive Moves
  • 12/20/2024China Licenses First Wholly Foreign-Owned Third-Grade General Hospital...
  • 12/20/2024CDE Issues the List of Reference Formulations for GQCE Studies (86th B...
  • 12/19/2024BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
  • 12/19/2024FDA Approves Betta/Xcovery's Ensartinib for NSCLC
  • 12/19/2024Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
  • 12/19/2024Aadi Partners with WuXi Bio and DAC for Next-Gen ADCs, Secures $100M P...
  • 12/18/2024Medical Costs in China Expected to Surge by 10.8% in 2025 amid Rising ...
  • Page:17/47 Total number of articles:1389: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group